BioMérieux S.A.
BIM
Rangering i aksjer
#1761
bioMérieux S.A. is a global entity operating across the Americas, Europe, the... bioMérieux S.A. is a global entity operating across the Americas, Europe, the Middle East, Africa, and the Asia Pacific, specializing in the development and production of in vitro diagnostic solutions. The company's sophisticated systems utilize biological samples to identify infectious diseases, cardiovascular conditions, and various forms of cancer. Additionally, bioMérieux provides essential microbiological testing services for the manufacturing sectors, primarily serving the food, pharmaceutical, cosmetics, and veterinary industries. Its client base includes clinical and hospital laboratories, medical practitioners, blood banks, and industrial quality control facilities. Founded in 1963, originally under the name B-D Mérieux, bioMérieux S.A. maintains its headquarters in Marcy l'Etoile, France, and functions as a subsidiary of Institut Mérieux SA.
Aksjekurs
$103.91
Markedsverdi
$12.23B
Endring (1 dag)
0.86%
Endring (1 år)
-19.74%
Land
FR
Handel BioMérieux S.A. (BIM)
Kategori
Healthcare
Inntekter for BioMérieux S.A. (BIM)
Inntekter i Jun 2026 TTM: $720.00M
Ifølge BioMérieux S.A. sine nyeste økonomiske rapporter er selskapets nåværende resultat $720.00M. I 2023 hadde selskapet et resultat på $483.64M, en nedgang sammenlignet med resultatet i 2022, som var $590.19M. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for BioMérieux S.A. fra 2005 til 2026
Inntekter ved slutten av hvert år
| År | Inntekter | Endre |
|---|---|---|
| 2026 (TTM) | $720.00M | 19.44% |
| 2024 | $602.80M | 24.64% |
| 2023 | $483.64M | -18.05% |
| 2022 | $590.19M | -30.64% |
| 2021 | $850.93M | 41.32% |
| 2020 | $602.12M | 68.44% |
| 2019 | $357.47M | -2.94% |
| 2018 | $368.30M | 5.12% |
| 2017 | $350.37M | 28.57% |
| 2016 | $272.52M | 42.44% |
| 2015 | $191.32M | -15.53% |
| 2014 | $226.50M | -32.25% |
| 2013 | $334.30M | 13.34% |
| 2012 | $294.95M | -4.15% |
| 2011 | $307.71M | -4.66% |
| 2010 | $322.75M | 11.10% |
| 2009 | $290.50M | 14.03% |
| 2008 | $254.76M | 12.73% |
| 2007 | $225.98M | 12.99% |
| 2006 | $200.00M | 22.21% |
| 2005 | $163.65M | 0.00% |
Inntekter for lignende selskaper eller konkurrenter
| Selskap | Inntekter | Forskjell i inntekter | Land |
|---|---|---|---|
| $7.61B | 956.81% |
US
|
|
| $4.76B | 561.39% |
US
|
|
| $-252.70M | -135.10% |
US
|
|
| - | - |
CN
|
|
| $1.66B | 130.28% |
US
|
